A Phase 2 Study of KZR-616 to Evaluate Safety and Efficacy in Patients With Active Polymyositis or Dermatomyositis
Conditions:   Polymyositis;   Dermatomyositis Interventions:   Drug: KZR-616;   Drug: Placebo Sponsor:   Kezar Life Sciences, Inc. Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 26, 2019 Category: Research Source Type: clinical trials

A Study of Ustekinumab in Participants With Active Polymyositis and Dermatomyositis Who Have Not Adequately Responded to One or More Standard-of-care Treatments
Conditions:   Polymyositis;   Dermatomyositis Interventions:   Drug: Ustekinumab 6 mg/kg;   Drug: Ustekinumab 90 mg;   Drug: Placebo IV;   Drug: Placebo SC Sponsor:   Janssen Pharmaceutical K.K. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 11, 2019 Category: Research Source Type: clinical trials

Spontaneous Coronary Artery Dissection (SCAD) and Autoimmunity
Conditions:   SCAD;   Addison Disease;   Ankylosing Spondylitis;   Antiphospholipid Antibody Syndrome;   Celiac Disease;   Crohn Disease;   Dermatomyositis;   Polymyositis;   Guillain-Barre Syndrome;   Hepatitis, Autoimmune;   Graves Disease;   Hashimoto Thyroiditis;   Multiple Sclerosi s;   Myasthenia Gravis;   Pernicious Anemia;   Polymyalgia Rheumatica;   Primary Biliary Cirrhosis;   Psoriasis;   Rheumatoid Arthritis;   Systemic Scle...
Source: ClinicalTrials.gov - May 7, 2019 Category: Research Source Type: clinical trials

A Study to Evaluate VIB7734 in Participants With Systemic Lupus Erythematosus (SLE), Cutaneous Lupus Erythematosus (CLE), Sjogren's Syndrome, Systemic Sclerosis, Polymyositis, and Dermatomyositis
Conditions:   Systemic Lupus Erythematosus;   Cutaneous Lupus Erythematosus;   Sjogren's Syndrome;   Systemic Sclerosis;   Polymyositis;   Dermatomyositis Interventions:   Drug: VIB7734;   Drug: Placebo Sponsor:   Viela Bio Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 25, 2019 Category: Research Source Type: clinical trials

Predictor of Clinical Response to Acthar in Myositis
Conditions:   Myositis;   Dermatomyositis;   Polymyositis Interventions:   Other: Healthy Control;   Other: Myositis in Remission Sponsor:   University of Pittsburgh Enrolling by invitation (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 29, 2018 Category: Research Source Type: clinical trials